268. Nakajo-Nishimura syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trial : 0 / Drug : 0 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Drugs and their primary sponsors and trial info
Baricitinib   
   Eli Lilly and Company
      2020   Phase 2/Phase 3   NCT04517253   Japan;